GENEDX (WGS) CEO Stueland Sells $1.0M in Stock After Option Exercise
GeneDx chief executive Katherine Stueland exercised 18,750 options and sold 10,501 Class A shares at prices between $94.26 and $99.00 on September 16.
GeneDx Holdings (WGS) chief executive Katherine Stueland exercised options on 18,750 Class A shares and sold 10,501 shares on the open market on 16 September, according to a Form 4 filed with the Securities and Exchange Commission. The combined value of the open-market transactions was roughly $1,025,013.
